EMEA-001454-PIP05-18

Key facts

Invented name
Mektovi
Active substance
binimetinib
Therapeutic area
Oncology
Decision number
P/0037/2019
PIP number
EMEA-001454-PIP05-18
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of colorectal carcinoma
Route(s) of administration
Oral use
Contact for public enquiries
Pierre Fabre Médicament
Tel. +33 800326326
E-mail: medical_information@pierre-fabre.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating